(Q50567163)

15 March 2018

title

The Danish National Project of interferon-beta treatment in relapsing-remitting multiple sclerosis. The Danish Multiple Sclerosis Group. (English)

1 reference

15 March 2018

relapsing-remitting multiple sclerosis

main subject

0 references

multiple sclerosis

0 references

author

Per Soelberg Sørensen

series ordinal

2

object named as

P S Sørensen

1 reference

15 March 2018

N Koch-Henriksen

1

1 reference

15 March 2018

publication date

1 June 2000

1 reference

15 March 2018

Multiple Sclerosis Journal

published in

1 reference

15 March 2018

volume

6

1 reference

15 March 2018

issue

3

1 reference

15 March 2018

page(s)

172-175

1 reference

15 March 2018

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

cites work

1 reference

https://api.crossref.org/works/10.1177%2F135245850000600306

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245850000600306

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245850000600306

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245850000600306

10.1177/135245850000600306

21 January 2018

Identifiers

DOI

1 reference

15 March 2018

PubMed ID

10871828

1 reference

15 March 2018